We thank Dr Goichot and colleagues for their letter and for their contribution to our guidelines. Their observations regarding thyroid dysfunction during amiodarone use are important, especially when it is recognized that this drug has been used in Europe for much longer than it has in the United States.
Goldschlager N, for the Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Amiodarone-Induced Hyperthyroidism—Reply. Arch Intern Med. 2001;161(2):295. doi: